Neurobiological aspects of addictions

Journal of Addictions Nursing

Volumn 12, Issue 3-4, 2000, Pages 117-132

  Wilcox, Richard E ^a   Erickson, Carlton K ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0041459825     PISSN: 10884602     EISSN: 15487148     Source Type: Journal    
DOI: 10.3109/10884600009041771     Document Type: Review

References (65)

1. Alterman AI, Droba M, et al. Amantadine may facilitate detoxification of cocaine addicts. Drug Alcohol Depend 31:19-29, 1992.
2. Ascher JA, Cole JO, et al. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 56:395-401, 1995.
3. Berke JS and Hyman SE. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25515-532, 2000.
4. Bigelow GE, Brooner RK, and Silverman K. Competing motivations: drug reinforcement vs. non-drug reinforcements. J Psychopharmacol 12:8-14, 1998. (Pubitemid 28142994)
5. Brady RO. Potential gene therapy for alcoholism. In:Toward a Molecular Basis of Alcohol Use and Abuse. B Jansson, H Jornvall, U Rydberg, L Terenius and BL Vallee (eds.) Basel, Switzerland, Birkhauser Verlag: 383-393, 1994.
6. Brick J and Erickson CK. Drugs, the Brain, and Behavior: The Pharmacology of Abuse and Dependence. Birmingham, NY, Haworth Press: 159-165, 1998.
7. CNN. Epilepsy drug may block cocaine addiction, Aug. 5, 1998. http://www.cnn.com/HEALTW9808/05/antiaddiction.drugl (Accessed March 13, 2001.)
8. Chick J, Erickson CK, and the Amsterdam Consensus Conference Participants. Consensus conference on alcohol dependence and the role of pharmacotherapy in its treatment. Alc Clin Exp Res 20:391-402, 1996. (Pubitemid 26119635)
9. Cloninger CR. Genetics of Substance Abuse. In Textbook of Substance Abuse Treatment. Galanter, M and Kleber, HD (eds.) Washington DC, American Psychiatric Press: 59-66, 1999.
10. Constentin J, Marcais H, Protais P, Baudry M, Delabanme S, Matres MP and Schwartz JC. Rapid development of hypersensitivity of striatal dopamine receptors induced by alphamethylparatyrosine and its prevention by protein synthesis inhibitors. Life Sci 21:307-314, 1977.
11. Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychophamzacol 12:54-57, 1998.
12. Eichenbaum HB, Cahill LF, et al. Learning and memory: systems analysis. In Fundamental Neuroscience. MJ Zigmond, FE Bloom, SC Landis, (eds.) San Diego, Academic Press 1455-1486, 1999
13. Emrick CD. Alcoholics anonymous and other 12-step groups. In Textbook of Substance Abuse Treatment. M Galanter, and HD Kleber (eds.). Washington DC, American Psychiatric Press: 403-412, 1999.
14. Erickson CK. Voice of the victims: there is a difference between alcohol abuse and alcoholism. Alcoholism: Clinical and Experimental Research 19: 533-534, 1995.
15. Erickson CK. Review of neurotransmitters and their role in alcoholism treatment. Alcohol & Alcoholism 31(Suppl. 1):5-11, 1996. (Pubitemid 26150739)
16. Erickson CK. Voices of the afflicted: How does alcoholism treatment work? A neurochemical hypothesis. Alcoholism: Clinical and Experimental Research 21:567-568, 1997.
17. Erickson CK. "Voices of the afflicted: What is impaired control?" Alcoholism: Clinical and Experimental Research 22: 132-133, 1998.
18. Erickson CK, Wilcox, RE, et al. Education of nonscientists about new alcohol research: Results of two types of presentations plus 6-month follow-up. Alcohol Clin Exp Res 22: 1890-1897, 1998. (Pubitemid 29031004)
19. Galanter M and Kleber HD. Textbook of substance abuse treatment, second edition. Washington, D.C., American Psychiatric Press, 1999.
20. Gallant D. Alcohol. In Textbook of Substance Abuse Treatment. M Galanter, and HD Kleber (eds.). Washington DC, American Psychiatric Press, Inc.: 151-164, 1999.
21. Gerasimov MR, Ashby CR Jr, Gardner EL, Mills MJ, Brodie JD and Dewey SL. Gammavinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine. Synapse 34: 11-19, 1999 (Pubitemid 29420291)
22. Goldstein A. Addiction: From Biology to Drug Policy. New York NY, W.H. Freeman and Co, 1994.
23. Grabowski J, Roache J, Schmitz J, et al. Replacement medication for cocaine dependence: methylphenidate. J Clin Psychopharmacol 17:485-488, 1997. (Pubitemid 28389189)
24. Greengard P, Allen PB, and Nairn AC. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23:435-447, 1999. (Pubitemid 29359916)
25. Greenstein-Messica A and Ruppin E. Synaptic runaway in associative networks and the pathogenesis of schizophrenia. Neural Comput 10:451-465, 1998. (Pubitemid 128463161)
26. Guze S. The genetics of alcoholism: 1997. Clin Genet 52:398-403, 1997. (Pubitemid 28068631)
27. Harlan RE and Garcia MM. Drugs of abuse and immediate early genes in the forebrain. Mol Neurobiol 16:221-267, 1998. (Pubitemid 28268545)
28. Harris RA, Mihic S, Valenzuela J, and Fernando C. Alcohol and benzodiazepines: Recent mechanistic studies. Drug and Alcohol Dependence 5 1 : 155-164, 1998.
29. Hurt RD, Sachs D, et al. A comparison of sustained- release bupropion and placebo for smoking cessation. N Engl J Med 337: 1195-1202, 1997. (Pubitemid 27454451)
30. Khantzian EJ, Gawin F, Kleber HB, et al. Methylphenidate (Ritalin) treatment of co-caine dependence: a preliminary report. J Substance Abuse Treat 1:107-112, 1984. (Pubitemid 14009508)
31. Kleber HD. Pharmacotherapy, current and potential, for the treatment of cocaine dependence. Clin Neuropharmacol 13(Suppl. 1): S96-S109, 1995.
32. Konradi C, Cole RL, Heckes S, and Hyman SE. Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J Neurosci 14: 5623-5634, 1994. (Pubitemid 24279078)
33. Koob GF, Sanna PP, and Bloom FE. Neuroscience of addiction. Neuron 21 :467-476, 1998. (Pubitemid 28475499)
34. Kranzler HR, Modcoto-Lowe V, and Nuwayser ES. Sustained-releast naltrexone for alcoholism treatment: a preliminary study. Alcohol Clin Exp Res 22:1074-1079, 1998. (Pubitemid 28408999)
35. Kuhn C, Swartzwelder S, and Wilson W. Buzzed. New York NY, W.W. Norton and Co., 1998.
36. Leshner Al. Addiction is a brain disease. Science 278:45-47, 1997.
37. Lutwick LI. Unconventional vaccine targets: Immunization for pregnancy, peptic ulcer, gastric cancer, cocaine abuse, and atherosclerosis. Infectious Disease Clinics of North America 13( 1):245-264, 1999. (Pubitemid 29164375)
38. Mason B. Alcohol researchers identify medication that lessens relapse risk, Aug. 31, 1999, Doctor's Guide. http://www.pslgroup.com/dg/l27466.htm. Accessed March 15, 2001.
39. Mason GJ, Ritvo EC, Morgan RO, et al. A double- blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HC1 for alcohol dependence. Alcohol Clin Exp Res 18:1162-1167, 1994. (Pubitemid 24345524)
40. McCance-Katz E, Sevarino K, et al. Pharmacotherapy of stimulant dependence: one of Japan's greatest public health challenges. Nihon Shinkei Seishin Yakurigaku Zasshi 19(4): 159-186, 1999
41. McKim WA. Drugs and behavior: an introduction to behavioral pharmacology. Upper Saddle River, New Jersey, Prentice Hall: 2000.
42. Mello NK, Mendelson JH, Kuehnle JC, et al. Operant analysis of human heroin selfadministration and the effects of naltrex-one. J Pharmacol Exp Ther 216:45-54, 1981. (Pubitemid 11167856)
43. O'Donnell P and Grace AA. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schiz Bull 2492:267-283, 1998. (Pubitemid 28404985)
44. O'Malley SS, Jaffe AJ, Chang G, et al. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 49381-887, 1992.
45. O'Neill JT. Voice of the victims: the key to consensus and support for alcohol research. Alcohol & Alcoholism 13(Suppl. 1):83-87, 1996.
46. Piazza PV, Deminiere JM, Le Moal M, and Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 245:1511-1513, 1989. (Pubitemid 19243245)
47. Robbins TW and Everitt BJ. Drug addiction: bad habits add up. Nature 398: 567-570, 1999. (Pubitemid 29183674)
48. Robinson TE, Browman KE, Crombag HS, and Badiani A. Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration. Neurosci Biobehuv Rev 22: 347-354, 1998 (Pubitemid 28194391)
49. Robinson TE and Berridge KC. The psychology and neurobiology of addiction: An incentive-sensitization view. Addiction 95, (Suppl. 2): S91-S117, 2000. (Pubitemid 30650375)
50. Robinson TE and Berridge KC. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research Reviews 18:247-291, 1993. (Pubitemid 23219500)
51. Rolls ET. The orbitofrontal cortex. Philos Trans R SOC Lond B Biol Sci 351:1433-1444,1996. (Pubitemid 27005370)
52. Rouge-Pont F, Piazza PV, Kharouby M, Le Moal M, and Simon H. Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration: A microdialysis study. Brain Res 602: 169-174, 1993 (Pubitemid 23045609)
53. Sass H, Soyka M, Mann K, et al. Relapse prevention by acamprosate: results from a placebocontrolled study on alcohol dependence. Arch Gen Psychiatry 53:673-680, 1996. (Pubitemid 26269327)
54. Schatzberg AF and Nemeroff CB. Textbook of Psychopharmacology, American Psychiatric Press, Inc., 1998.
55. Schuckit MA. Drug and Alcohol Abuse. New York NY, Plenum Medical Book Co. 1995a.
56. Schuckit MA. Educating Yourself About Alcohol and Drugs: A People's Primer. New York NY, Plenum Press. 1995b.
57. Senay EC. Opioids: methadone maintenance. In Textbook of Substance Abuse Treatment. Galanter, M and Kleber, HD (eds.) Washington DC, American Psychiatric Press:271-280, 1999
58. Shaham Y and Steward J. Stress reinstrates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychophumcology (Bed.) 119:334-341, 1995.
59. Silva AJ, Kogan JH, Frankland PW, and Kida S. "CREB and memory." Annu Rev Neurosci 21: 127-148, 1998. (Pubitemid 28150661)
60. Volpicelli JR, Alterman AI, Hyashida M, et al. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49( 11): 876-880, 1992.
61. White NM. Addictive drugs as reinforcers: Multiple partial actions on memory systems. Addiction 91 (7):921-949, 1996. (Pubitemid 26234322)
62. Wilcox RE, Smith RV, Anderson JA, and Riffee WH. Apomorphine-induced stereotypic cage climbing in mice as a model for studying changes in dopamine receptor sensitivity. Phamuzcol Biochem Behav. 12:29-33, 1980. (Pubitemid 10155080)
63. Wilcox RE, Gonzales RA, and Miller JD. Introduction to neurotransmitters, receptors, signal transduction, and second messengers. In Textbook of Psychopharmacology. AF Schatzberg and CB Nemeroff (eds.) American Psychiatric Press: 3-36, 1998.
64. Wilcox RE. Dopamine. In Encyclopedia of Psychology & Neuroscience. WE Craighead and CB Nemeroff (eds.) New York, John Wiley. 2000.
65. Wilcox RE and McMillen BA. The rational use of drugs as therapeutic agents for the treatment of the alcoholisms: A commentary. Al-cohol 15:161-177, 1998 (Pubitemid 28099248)